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1  | INTRODUC TION
Hypertrophic cardiomyopathy (HCM) is the most common cause 
of sudden cardiac death in the young and in athletes (Maron, 
Doerer, Haas, Tierney, & Mueller, 2009; Maron, Haas, Murphy, 
Ahluwalia, & Rutten‐Ramos, 2014). The disease is characterized 
by ventricular repolarization abnormalities arising from structural 
changes of cellular hypertrophy, interstitial fibrosis, and myofiber 
disarray and on the other hand from disturbances in the ion cur‐
rents and calcium handling on the molecular and cellular level. In 
combination, these changes constitute the arrhythmic substrate 
responsible for the risk of malignant ventricular arrhythmias 
(Coppini et al., 2013; Maron, 2010). The stratification of risk for 
malignant ventricular arrhythmias in HCM is based on multiple 
factors, but even with current clinical guidelines gaps remain 
(Elliott et al., 2014).
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Abstract
Background: Hypertrophic cardiomyopathy (HCM) is characterized by ventricular 
repolarization abnormalities and risk of ventricular arrhythmias. Our aim was to study 
the association between the phenotype and ventricular repolarization dynamics in 
HCM patients.
Methods: HCM patients with either the MYBPC3‐Q1061X	or	TPM1‐D175N mutation 
(n = 46)	and	control	subjects	without	mutation	and	hypertrophy	(n = 35) were stud‐
ied with 24‐hr ambulatory ECG recordings by measuring time intervals of rate‐
adapted QT (QTe), maximal QT, and T‐wave apex to wave end (TPE) intervals and the 
QTe/RR slope. Findings were correlated to specified echocardiographic and cardiac 
magnetic resonance imaging (CMRI) findings.
Results: Rate‐adapted QTe interval was progressively longer in HCM patients with 
decreasing heart rates compared to control subjects (p = 0.020). The degree of hy‐
pertrophy correlated with measured QTe values. HCM patients with maximal wall 
thickness	higher	than	the	mean	(20.6	mm)	had	longer	maximum	QTe	and	median	TPE	
intervals compared to control subjects and HCM patients with milder hypertrophy 
(p < 0.001 and p = 0.014, respectively). HCM patients with late gadolinium enhance‐
ment (LGE) on CMRI had steeper QTe/RR slopes compared to HCM patients without 
LGE and control subjects (p = 0.044 and p = 0.001, respectively). LGE was an inde‐
pendent predictor of QTe/RR slope (p = 0.023, B = 0.043).
Conclusion: Dynamics of ventricular repolarization in HCM are affected by hypertro‐
phy and fibrosis. LGE may confer an independent effect on QT dynamics which may 
increase the arrhythmogenic potential in HCM.
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The QT interval is prolonged in HCM and modestly cor‐
relates	with	maximal	wall	thickness	(Johnson	et	al.,	2011).	The	
QTe/RR slope has been found steeper in higher risk patients 
and the QT variance index was slightly elevated in HCM pa‐
tients with clinically significant arrhythmias (Orosz et al., 2015; 
Quinteiro et al., 2015). However, data on ventricular repolar‐
ization dynamics and their association to the HCM geno‐ and 
phenotype are limited.
Fibrosis, as measured by late gadolinium enhancement (LGE) 
on cardiac magnetic resonance imaging (CMRI), is a promising addi‐
tion to the risk assessment of hypertrophic cardiomyopathy and is 
a predictor of sudden cardiac death (SCD)(Chan et al., 2014; Weng 
et	al.,	2016).	The	areas	of	fibrosis	in	the	left	ventricle	(LV)	provide	a	
substrate for ventricular arrhythmias and affect repolarization pa‐
rameters in monophasic action potential recordings (Sakamoto et al., 
2015). The association of LGE to ventricular repolarization dynamics 
on the surface ECG is unclear. The aim of this study was to explore 
the dynamics of ventricular repolarization in HCM using ambulatory 
ECG recordings and analyze the association of hypertrophy and late 
gadolinium enhancement to the degree of ventricular repolarization 
disturbances.
2  | METHODS
2.1 | Subjects
Adult Finnish HCM patients carrying either the MYBPC3‐Q1061X	
or TPM‐D175N founder mutation for HCM were recruited prospec‐
tively during 2000–2012. HCM was defined in mutation carriers as 
maximal	wall	thickness	(MWT)	≥13	mm	and	no	other	cause	for	sig‐
nificant hypertrophy. Exclusion criteria were nonsinus rhythm, bun‐
dle branch block or implanted pacemaker precluding CMR imaging. 
Of the screened 52 HCM patients, six were excluded on grounds 
of nonsinus rhythm (n = 4) or bundle branch block (n = 2). In total, 
46	HCM	patients	were	included	in	the	study.	Individuals	without	ei‐
ther of the gene mutations or hypertrophy constituted the control 
group (n = 35). The Ethics Committees at the Kuopio and Helsinki 
University Hospitals approved the study protocol. The study con‐
forms to the principles outlined in the Declaration of Helsinki.
2.2 | Baseline data
Venous	blood	samples	were	collected	and	measured	for	creatinine	
and the plasma concentrations of the N‐terminal portion of brain 
natriuretic peptide (NT‐proBNP). Immunoassays utilizing antisera di‐
rected to NT‐proBNP were used and the sensitivity of the assay was 
40 pmol/L (Ala‐Kopsala et al., 2005). As previously described, the 
genetic studies were performed in the Genome Center of Eastern 
Finland	(Jääskeläinen	et	al.,	2002).	Normal	12‐lead	ECG	recordings	
were obtained from subjects and measured for conventional param‐
eters of heart rate, QT‐interval duration and corrected QT‐interval 
(using the Bazett formula).
2.3 | Ambulatory ECG analysis
Twenty‐four‐hour ambulatory ECGs were digitally recorded on 
Marquette commercial AECG systems and postprocessed with 
a custom software built in collaboration with Aalto University. 
Overall quality of the recording was assessed visually using all 
the available channels (2 or 3 channels). All data were processed 
and	measured	from	the	modified	precordial	lead	V5.	All	nonsinus	
beats were excluded. The methodology of data processing and al‐
gorithms for determining QRS onset, offset and T‐wave peak and 
T	wave	end	have	been	previously	described	(Viitasalo,	Oikarinen,	
Väänänen	 et	al.,	 2002).	 T‐wave	 peak	was	 identified	 as	 the	 peak	
of the parabola fitted to the highest amplitude change after the 
QRS. T‐wave end was defined as the time instant where the steep‐
est tangent after the T‐wave peak intersects the baseline. The re‐
cording was further processed by excluding beats with T waves of 
low	amplitude	(−0.1	to	0.1	mV)	and	beats	where	either	the	T‐wave	
peak or end was not identified by the algorithm. All beats with a 
noise	 level	>0.02	mV	and	beats	with	an	RR	interval	change	from	
the preceding beat of >30% were excluded. Data were further 
checked by plotting time interval values of from onset of Q wave 
to T‐wave peak (QTp), onset of Q wave to T‐wave end (QTe) and 
T‐wave peak to T‐wave end (TPE) against the preceding respective 
RR intervals and manually removing outliers.
Using these plots, the median QTe, QTp and TPE values were 
measured	at	100	ms	RR	intervals	from	600	to	1,200	ms.	To	assess	
the rate dependence of QTe and QTp intervals, we calculated heart 
rate‐adapted values of median QTe and QTp values using periods of 
stable	heart	 rate	 for	60	s	 (beat‐to‐beat	RR	 interval	variation	≤10%	
in	RR	steps	of	10	ms)	as	described	previously	(Viitasalo,	Oikarinen,	
Väänänen	et	al.,	2002).	The	maximum	values	of	QTe,	QTp,	and	TPE	
were measured from the QTe‐RR, QTp‐RR and TPE‐RR plotted data 
at	100	ms	intervals	from	600	to	1,200	ms.	The	mean	of	three	sepa‐
rate measurements of maximal value were calculated for each time 
point, with a requisite of variance of no more than 5% between the 
measured data points and visual confirmation of data quality and 
stability of at least five consecutive beats around the measured beat. 
A fitted regression line to the QTe‐RR plot (data from RR intervals 
600	 to1,200	ms)	 of	 the	 form	 y = ax + b was used to measure the 
QTe/RR slope (a) and intercept b (Figure 4b).
2.4 | Echocardiography
Echocardiographic measurements were performed locally at 
Helsinki and Kuopio University Hospitals by experienced cardiolo‐
gists	(MJ,	PJ,	JK)	using	GE	Vivid	7	and	9	ultrasound	equipment	(GE	
Vingmed	Norway).	Conventional	echocardiographic	measurements	
were performed according to current guidelines. Left ventricu‐
lar	 ejection	 fraction	 (LVEF)	was	measured	using	Simpson’s	biplane	
method.	Left	ventricular	outflow	tract	(LVOT)	maximal	flow	velocity	
was measured by continuous wave Doppler (gradient >30 mmHg on 
echocardiography considered significant).
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2.5 | Cardiac magnetic resonance imaging
Cardiac magnetic resonance imaging was performed using a 1.5‐T 
clinical MR imaging unit in both Helsinki and Kuopio University 
Hospitals. Late gadolinium enhancement imaging was performed as 
part of protocol. All CMRI data were analyzed by three experienced 
radiologists (PS, MT, KL) blinded to clinical data and normal measure‐
ments	including	LV	volumes	and	function	were	performed	according	
to guidelines. Late gadolinium enhancement was assessed visually and 
reported as a binary variable (present/absent). Mean MWT on CMRI 
in	the	HCM	patients	was	20.6	mm.	This	was	used	as	a	cutoff	value	to	
investigate	the	effect	of	mild	 (<20.6	mm)	and	moderate	 (>20.6	mm)	
wall thickness on ventricular repolarization measurements.
2.6 | Statistics
Data are presented as mean and standard deviation for normally dis‐
tributed continuous data, median and interquartile range for nonpara‐
metric data and count and percentage for categorical data. Differences 
between groups of normally distributed data were analyzed with in‐
dependent t tests for two group comparisons and one‐way analysis of 
variance	(ANOVA)	for	three	group	comparisons	with	post	hoc	pairwise	
tests using Bonferroni correction. Nonparametric data were compared 
between groups with Kruskal‐Wallis test with pairwise comparisons 
by	using	Bonferroni	correction	and	Fisher’s	exact	test	for	categorical	
data. The multiple measurements of QTe, QTp, and TPE from QT‐RR 
plots at 100 ms intervals were analyzed with repeated measurements 
analysis	 of	 variance	 (RM‐ANOVA)	 for	 statistical	 difference	between	
groups and post hoc Bonferroni correction for pairwise comparisons. 
The subscript in QTe1000, QTp1000, and TPE1000 denotes a measure‐
ment at 1,000 ms RR interval. Univariate correlations were analyzed 
with Spearman rank correlation. Linear regression was used to analyze 
the predictive value of age, gender, beta blocker therapy, CMRI MWT 
and LGE on the QTe/RR slope. All statistical tests were considered sig‐
nificant with a two‐way level of <0.05. All statistical analyses were per‐
formed	with	IBM	SPSS	Version	21.0	(IBM	Corp.	Released	2012.	IBM	
SPSS	Statistics	for	Windows,	Version	21.0.	Armonk,	NY:	IBM	Corp.)
3  | RESULTS
3.1 | Baseline
The baseline variables are presented in Table 1. The study groups 
were balanced regarding age and blood pressure. No difference was 
observed in the sex distribution. HCM patients were mostly asymp‐
tomatic (78%). Creatinine was marginally higher in the HCM group 
but within normal limits. NT‐proBNP values were higher in the HCM 
patients. Approximately, half of the HCM patients had the MYBPC3‐
Q1061X	 and	 the	 other	 half	 had	 the	 TPM1‐D175N mutation. Beta 
blocker use was common in the HCM group. No drugs affecting the 
QT interval were used by the HCM patients. The mean heart rates 
on the ambulatory ECGs were similar. The peak heart rate in the 
HCM group was lower compared to the control group.
3.2 | Imaging
The	imaging	variables	are	presented	in	Table	2.	LVEF	and	end‐di‐
astolic	volumes	were	similar	between	groups.	LV	end‐diastolic	di‐
ameter was slightly larger in the control group. HCM patients had 
larger left atria and slower early diastolic filling as measured by 
TA B L E  1   Baseline variables
Control 
(n = 35)
HCM 
(n = 46) p‐Value
Baseline
Age (years) 43.3 ± 14.8 45.5 ± 11.7 0.456
Male 37% (13) 59% (27) 0.073
BMI 25.1 ± 3.8 27.2 ± 5.4 0.052
BP Systolic (mmHg) 131 ± 13 130 ± 15 0.859
BP Diastolic 
(mmHg)
77 ± 10 80 ± 10 0.187
Hypertension 22% (10)
NYHA
I 78%	(36)
II 22% (10)
Beta blocker 48% (22)
ACEi or ARB 12%	(6)
Creatinine (mmol/L) 75 ± 19 85 ± 15 0.015
NT‐proBNP 
(pmol/L)
41 (3) 81 (194) <0.001
Mutation
 MYBPC‐Q1061X 52% (24)
 TPM‐D175N 48% (22)
ECG
HR (bpm) 63	±	10 62	±	10 0.693
QRS duration (ms) 89 ± 8 92 ± 11 0.396
QT (ms) 395 ± 32 421 ± 41 0.003
QTc (ms) 404 ± 31 424 ± 25 0.002
Twenty‐four‐hour ambulatory ECG
Mean HR (bpm) 67	±	6 65	±	6 0.106
Max HR (bpm) 139 ± 18 126	±	19 0.003
Min HR (bpm) 44 ± 8 43 ± 5 0.461
PAB 8 (22) 8 (18) 0.828
PVB 3 (12) 14 (82) 0.004
At	least	one	NSVT 26%	(12)
Number	of	NSVT 1	(1–16)
Duration	of	NSVT	
(beats)
5 (3–14)
Note. Data presented as mean ± SD or percentage (number of subjects) 
except	for	PAB	and	PVB	as	median	(interquartile	range)	and	for	number	
and	duration	of	NSVT	as	median	(range).
BMI: body mass index; BP: blood pressure; ACEi: angiotensin‐converting 
enzyme inhibitor; ARB: angiotensin receptor blocker; PAB: premature 
atrial	 beat;	 PVB:	 premature	 ventricular	 beat;	 NSVT:	 nonsustained	 
ventricular tachycardia.
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the deceleration time. As expected, the HCM patients had thicker 
ventricles. The location of maximal hypertrophy in HCM patients 
was mostly confined to the septum, with some patients having 
lateral wall hypertrophy and one patient had concentric hyper‐
trophy. Of HCM patients, 37% exhibited fibrosis as measured by 
CMRI gadolinium late enhancement. NTproBNP‐levels correlated 
Control (n = 35) HCM (n = 46) p‐Value
Echocardiography
LVEDD	(mm) 49 ± 5 44	±	6 <0.001
Maximal wall thickness (mm) 9.8 ± 1.3 18.5	±	5.6 <0.001
Septal wall thickness (mm) 9.1 ± 1.2 15.7 ± 5.9 <0.001
Posterior wall thickness (mm) 9.1 ± 1.4 10.2 ± 1.7 0.002
Left atrial diameter (mm) 33 ± 5 38	±	6 0.001
LVOT	gradient	(mmHg) 7.1	±	2.6 9.0 ± 10.7 0.737
MV	E	velocity	(m/s) 0.80 ± 0.15 0.71 ± 0.18 0.013
MV	A	velocity	(m/s) 0.56	±	0.17 0.63	±	0.23 0.350
MV	Deceleration	time	(ms) 199 ± 58 227	±	76 0.046
Cardiac magnetic resonance imaging
LVEF	(%) 60	±	7 62	±	8 0.152
LV	end‐diastolic	volume	index	
(ml/m2)
77 ± 12 76	±	15 0.906
LV	mass	index	(g/m2) 55 ± 15 71 ± 19 <0.001
Maximal wall thickness (mm) 10.0 ± 2.4 20.7 ± 5.2 <0.001
Location of hypertrophy
Septal 78%	(36)
Lateral wall 17% (8)
Concentric 2% (1)
Apical 0
Gadolinium late‐enhancement 37% (17) <0.001
Note. Data presented as mean ± SD or percentage (number of subjects).
LVEDD:	left	ventricular	(LV)	end‐diastolic	dimension;	LVOT:	left	ventricular	outflow	tract;	MV:	mitral	
valve;	LVEF:	left	ventricular	ejection	fraction.
TA B L E  2   Imaging variables
Repolarization Control (n = 35) HCM (n = 46) p‐Value 95% CI
QTe (ms) 380 ± 30 417 ± 43 <0.001 19.6	to	54.9
HR‐adapted QTe1000 
(ms)
403	±	26 426	±	34 0.002 9.2 to 37.4
Maximum QTe1000 
(ms)
440 ± 27 469	±	40 0.001 12.9 to 45.1 
QTe/RR slope 0.178	±	0.06 0.215	±	0.06 0.007 0.01	to	0.06
QTp (ms) 301 ± 29 323 ± 30 0.002 8.5 to 35.7
HR‐adapted QTp1000 
(ms)
320 ± 28 335 ± 27 0.017 2.8 to 28.2
Maximum QTp1000 
(ms)
355 ± 29 370 ± 30 0.031 1.3 to 28.7
TPE (ms) 80 ± 9 94	±	60 0.185 −7.0	to	35.7
Median TPE1000 (ms) 81 ± 11 87 ± 21 0.107 −1.45	to	14.5
Maximum TPE1000 
(ms)
103 ± 20 110 ± 29 0.315 −6.2	to	19.0
Note. Data presented as mean ± SD. The subscript 1,000 denotes measurement at 1,000 ms RR in‐
terval duration.
HCM: Hypertrophic cardiomyopathy; QTe: Q wave to T‐wave end; TPE: T‐wave peak to T‐wave end.
TA B L E  3   Repolarization measurements
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with both maximum QTe1000 (ρ = 0.390, p = 0.007) and QTe/RR –
slope (ρ	=	0.466,	p = 0.001).
3.3 | Repolarization parameters
The ventricular repolarization dynamics are presented in Table 3 and 
Figure 1. Mean QTe and QTp measured from all beats, median heart 
rate‐adapted QTe1000 and QTp1000, as well as maximum QTe1000 and 
QTp1000 were significantly different between study groups. In con‐
trast, no differences in TPE measurements between groups were 
found (Table 3). Figure 1a,b shows the heart rate‐adapted median 
QTe and maximum QTe in the two groups, with a significant dif‐
ference between HCM and control groups in repeated measures 
ANOVA	 (p = 0.020 and p = 0.011, respectively). The heart rate‐
adapted median QTp and maximum QTp values followed a similar 
pattern as measured QTe values but the differences between study 
groups were not statistically significant (Figure 1c,d). The QTe/RR 
slopes were also significantly different between HCM and control 
groups (Table 3). No statistical differences were found in repolariza‐
tion parameters of heart rate‐adapted QTe or QTp, maximum QTe 
or QTp, or maximum TPE between the two mutation types (p > 0.05 
for all). There was no effect of beta blocker therapy use on heart 
rate‐adapted QTe, maximum QTe or maximum TPE in QTe‐RR plots 
(p = 0.522, p = 0.779 and p = 0.790, respectively for repeated meas‐
ures	ANOVA).
3.4 | Repolarization and maximal wall thickness
In univariate Spearman rank correlation, there was a modest correla‐
tion of MWT to maximum QTe1000 (ρ = 0.319, p = 0.035). Assessing 
F I G U R E  1   Heart rate‐adapted QTe intervals (a), maximum QTe intervals (b), heart rate‐adapted QTp intervals (c), and maximum QTp 
intervals (d) at different heart rates
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the effect of MWT on ventricular repolarization, the HCM patients 
were divided into two groups according to MWT being below or 
above	the	mean	MWT	measured	on	CMRI	(20.6	mm).	The	maximum	
QTe1000	was	different	between	HCM/MWT	>	20.6	mm	and	HCM/
MWT	<	20.6	mm	 (p = 0.005 for pairwise comparison) and control 
subjects (p < 0.001 for pairwise comparison). Figure 2a shows the 
maximum QTe values in the three groups at different RR intervals. 
A significant deviation of the maximum QTe curves was observed at 
longer RR intervals from 900 to 1,200 ms. Median TPE was signifi‐
cantly longer in HCM patients with thicker MWT compared to HCM 
patients with milder hypertrophy (p = 0.021) or control subjects 
(p = 0.027) in pairwise comparisons. In contrast to QTe values, the 
TPE measurements differed more clearly at all RR‐intervals between 
groups (Figure 2b).
3.5 | Sex differences
MWT	 values	 were	 similar	 in	 HCM	 male	 (mean	 21.4	±	5.6	mm)	
and	 female	 (19.7	±	4.6	mm)	 patients	 (p = 0.301). The mean dif‐
ference in MWT between HCM patients and control subjects 
was	9.8	±	1.7	mm	 in	men	and	10.6	±	1.1	mm	 in	women	and	 the	
mean difference was not statistically significant between male 
and female subjects (p = 0.071). HR‐adapted QTe1000 in HCM vs. 
control subjects was 423 ± 37 ms vs. 384 ± 24 ms among men 
(p = 0.002) and 431 ± 30 ms vs. 412 ± 21 ms among women 
(p = 0.034), respectively. Figure 3 shows the rate‐adapted QTe‐
RR curves both for male and female control subjects and HCM 
patients. The ventricular repolarization dynamics were similar in 
both sexes. In male subjects, there was a trend toward a larger 
difference in HR‐adapted QTe values between HCM patients 
and control subjects at RR intervals 900–1,200 compared to 
women (Figure 3a).
3.6 | Repolarization and nonsustained ventricular 
tachycardia
There	were	12	(26%)	HCM	patients	with	at	least	one	recorded	episode	
of	nonsustained	ventricular	tachycardia	(NSVT,	Table	1).	HCM	patients	
with	NSVT	did	not	have	statistically	significant	differences	 in	median	
or maximal measured QTe, TPE or other repolarization parameters on 
24‐hr	ambulatory	ECG	in	comparison	to	HCM	patients	without	NSVT	
episodes.	On	a	smaller	note,	all	the	HCM	patients	with	NSVT	had	a	max‐
imum QTe1000 of at least 439 ms or higher (median 479 ms) compared 
to	HCM	patients	without	NSVT	(minimum	373	ms	and	median	464	ms).
3.7 | Repolarization and fibrosis
HCM patients with fibrosis by late gadolinium enhancement 
(HMC/LGE+, n = 17) exhibited steeper QTe/RR slopes compared to 
HCM	patients	without	 fibrosis	 (HCM/LGE−,	n = 29) or the control 
group (Figure 4, Table 4). No significant differences in other repo‐
larization parameters were found between HCM/LGE+ and HCM/
LGE−	 groups	 (Table	4).	 There	was	 no	 difference	 in	 the	 age	 or	 sex	
distribution	 between	 HCM/LGE+	 and	 HCM/LGE−	 patients	 (mean	
age 42.5 years and 50.8 years, p = 0.118, male subjects 59% in both 
groups, p = 1.000)	or	MWT	(mean	CMRI	MWT	20.4	mm	vs.	21.6	mm,	
p = 1.000). In linear regression of LGE, CMRI MWT, age, gender and 
beta blocker use to QTe/RR slope, the presence of LGE was the only 
independent predictor (p = 0.023, B = 0.043).
4  | DISCUSSION
The principal findings in this study are: (a) HCM patients show pro‐
gressively longer heart rate‐adapted QTe interval with decreasing 
F I G U R E  2   Maximum QTe intervals (a) and median TPE (b) at different heart rates in three groups according to maximal wall thickness
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heart rates than normal subjects; (b) In HCM, the degree of hyper‐
trophy prolongs the maximal QTe interval; (c) The QTe/RR slope is 
steeper in HCM than control subjects; (d) HCM patients with LGE 
show steeper QTe/RR slopes than HCM patients without LGE and 
LGE is an independent predictor of QTe/RR slope.
We found that the QTe/RR slope was steeper in HCM patients 
with LGE than those without LGE. In addition, the presence of LGE 
was the only independent predictor for the steepness of the QTe/
RR slope. Previously, a steeper QTe/RR slope has been associated 
with increased risk of SCD in ischemic patients (Chevalier et al., 
2003; Milliez et al., 2005) and overall mortality in heart failure 
(Cygankiewicz et al., 2008; Pathak et al., 2005; Watanabe et al., 
2007). In a study of HCM patients, Quinteiro et al. found the QTe/RR 
slope steeper in individuals classified as high risk based on conven‐
tional risk criteria. Notable in that study was the significant differ‐
ence in MWT between low and high risk patients (20 mm vs. 25 mm). 
Although in this study, MWT was associated to prolongation of the 
QTe, in linear regression the only independent predictor of QTe/RR 
slope was LGE. In a large cohort of nearly 1,300 HCM patients, an 
LGE	extent	of	≥15%	of	the	LV	mass	was	associated	with	a	twofold	
risk of SCD in HCM patients otherwise classified as low risk (Chan 
et al., 2014). The fibrosis quantified with LGE may have an additional 
F I G U R E  3   Heart rate‐adapted QTe intervals for male (a) and female (b) subjects at different heart rates in the two study groups
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role	in	increasing	an	HCM	patient’s	risk	for	ventricular	arrhythmias	
through effects on the propagation of the repolarization current in 
the myocardium resulting in a steeper QTe/RR slope.
In this study, we found the QTe systematically prolonged in 
HCM patients, although to a lesser degree than in some previous 
reports. The reason for this may be, that the patients in this study 
were	relatively	asymptomatic	and	had	a	mean	MWT	of	20.6	mm	
on CMRI compared to, for example, a mean MWT of 24.1 mm in 
HCM	patients	with	a	pathological	QTc	of	≥480	ms	(13%	of	HCM	
patients)	 in	 a	 study	 by	 Johnson	 et	al.	 (2011).	 Prolonged	 QT	 in‐
terval is associated to increased risk for ventricular arrhythmias 
(Debonnaire et al., 2015) and independently of hypertrophy pre‐
dicts ICD therapy in HCM (Gray, Ingles, Medi, & Semsarian, 2013). 
In healthy individuals, the QT interval is dependent on heart rate 
in a curvilinear fashion. In this study, the heart rate‐adapted QTe 
in HCM patients prolonged with decreasing heart rates compared 
to control subjects, resulting in an increasing separation of the 
QTe curves seen in Figure 1a. This phenomenon is not related 
to the differences in distribution of RR intervals in the studied 
ambulatory ECGs. The methodology of using stable heart rates 
also diminishes the effect of sudden changes in RR intervals to 
the QTe. The measured maximal and heart rate‐adapted median 
QT peak values followed a very similar pattern to the QTe values 
and did not offer additional information to the established QTe 
measurements.
The patterns of ventricular repolarization dynamics were simi‐
lar between male and female patients with a slight trend for longer 
QTe values in the female HCM and control subjects. On the other 
hand, the differences in HR‐adapted QTe values between HCM and 
control subjects were larger in men as compared to women at RR 
intervals 900–1,200 ms (Figure 3). This was not explained by differ‐
ences in distribution of maximal wall thickness in male and female 
HCM patients.
Median TPE was significantly longer in HCM patients with 
MWT	>	20.6	mm	 compared	 to	 the	 control	 group	 in	 this	 study.	
Previously, TPE has been found prolonged in HCM but without anal‐
ysis of the association to structural changes (Shimizu et al., 2002). 
The TPE interval has been considered a measure of the global disper‐
sion of ventricular repolarization (Gupta et al., 2008; Opthof et al., 
2007) and based on our results is more evident with advanced HCM.
In experimental studies, the prolongation of ventricular repo‐
larization in HCM is the result of pathologies on many levels. The 
action potential is prolonged as the net repolarizing current is di‐
minished by increased late‐type Na and Ca2+ currents (INaL and ICaL) 
and selective down regulation of the outward rectifying current (IKr)
(Coppini	et	al.,	2013;	Crocini	et	al.,	2016;	Passini	et	al.,	2016).	The	
repolarization in the myocardium is also delayed due to hypertrophy 
(Badran et al., 2012) and global repolarization is spatially dispersed 
due to the asymmetric location of hypertrophy (Sakata et al., 2003). 
The pathophysiological abnormalities in potassium‐currents, es‐
pecially the reduction in IKr, resemble those found in type 2 LQTS 
patients and in agreement we found the prolongation of heart rate‐
adapted QTe and the prolongation of TPE interval mimicking the 
findings	 in	type	2	LQTS	patients	 (Viitasalo,	Oikarinen,	Swan	et	al.,	
2002;	Viitasalo,	Oikarinen,	Väänänen	et	al.,	2002).
Approximately, 20%–27% of ICD therapies in HCM patients 
occur	during	rest	 (Maron	et	al.,	2009;	O’Mahony	et	al.,	2012).	The	
repolarization alterations in this study increased with lower heart 
rates and may thus have a role in the ventricular arrhythmias occur‐
ring during phases of bradycardia in HCM patients.
4.1 | Limitations of the study
The study was limited in sample size resulting in part from the deci‐
sion to include only carriers of the two founder mutations. Because 
of the sample size, the possible effect of sex cannot be definitively 
ruled out in this study. We did not study the effect of location of 
hypertrophy on ventricular repolarization parameters, as the abso‐
lute number of patients with MWT not localized in the septal seg‐
ments was relatively small. The assessment of LGE was limited due 
to different acquisition protocols of CMR imaging and therefore 
the presence of LGE was assessed only visually with a binary scale 
because no reliable quantification of LGE extent was possible. The 
echocardiographic evaluation did not include comprehensive meas‐
urements of diastolic function. A number of HCM patients were on 
beta blocker therapy, which was not discontinued for this study. 
Beta blocking agents affect the heart rate and may have an influence 
on the QT to the heart rate relationship. In this study, the mean heart 
rates were similar between the two study groups and there was no 
difference in QTe values between HCM patients with and without 
beta blocker therapy.
TA B L E  4   Repolarization measurements in HCM patients with 
and without late gadolinium enhancement
Repolarization
HCM/LGE−  
(n = 29)
HCM/LGE+ 
(n = 17) p‐Value
QTe (ms) 422	±	46 410 ± 38 0.367
HR‐adapted 
QTe1000 (ms)
424	±	36 431 ± 32 0.545
Maximum QTe1000 
(ms)
468	±	43 470	±	36 0.886
QTe/RR slope 0.199	±	0.06 0.242	±	0.06 0.001
QTp (ms) 324	±	26 322 ± 38 0.856
HR‐adapted 
QTp1000 (ms)
324	±	26 322 ± 38 0.457
Maximum QTp1000 
(ms)
368	±	26 374 ± 38 0.578
TPE (ms) 99 ± 73 85	±	16 0.478
Median TPE1000 
(ms)
84 ± 18 94 ± 20 0.168
Maximum TPE1000 
(ms)
106	±	24 117 ± 37 0.263
Note. Data presented as mean ± SD. The subscript 1,000 denotes meas‐
urement at 1,000 ms RR interval duration.
HCM: Hypertrophic cardiomyopathy; LGE: late gadolinium enhance‐
ment; QTe: Q wave to T‐wave end; TPE: T‐wave peak to T‐wave end.
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5  | CONCLUSIONS
The QTe/RR slope is steeper in HCM patients with LGE indepen‐
dently of hypertrophy. The degree of QTe prolongation is associated 
to MWT. Overall, the heart rate‐adapted QTe is prolonged in HCM 
patients compared to control subjects. The repolarization dynamics 
in HCM reflect the underlying changes in the myocardium.
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